LaSalle St. Investment Advisors LLC bought a new stake in shares of Danaher Corporation (NYSE:DHR – Free Report) in the second quarter, Holdings Channel reports. The fund bought 4,484 shares of the conglomerate’s stock, valued at approximately $854,000.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Main Street Group LTD purchased a new position in shares of Danaher in the first quarter worth about $25,000. N.E.W. Advisory Services LLC bought a new stake in shares of Danaher during the second quarter valued at about $25,000. JPL Wealth Management LLC purchased a new stake in shares of Danaher in the third quarter worth about $25,000. WFA of San Diego LLC bought a new position in shares of Danaher in the second quarter valued at approximately $26,000. Finally, Hilton Head Capital Partners LLC bought a new position in shares of Danaher in the fourth quarter valued at approximately $27,000. Institutional investors own 79.05% of the company’s stock.
Danaher Stock Up 2.2%
Shares of DHR opened at $216.14 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The stock has a 50 day simple moving average of $195.01 and a two-hundred day simple moving average of $192.43. The firm has a market cap of $151.94 billion, a P/E ratio of 38.39, a P/E/G ratio of 2.63 and a beta of 0.78.
Analyst Ratings Changes
A number of analysts recently weighed in on DHR shares. Stifel Nicolaus decreased their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Wells Fargo & Company reduced their price target on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. Argus decreased their price target on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Friday, April 24th. Piper Sandler began coverage on Danaher in a research report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price objective on the stock. Finally, Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $228.91.
Read Our Latest Research Report on Danaher
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
